Inhibitory activity of commensals isolated from the bovine teat skin microbiota against the major mastitis pathogen Staphylococcus aureus by Astmann, Theresa J & Barlow, John W
University of Vermont 
ScholarWorks @ UVM 
UVM Honors College Senior Theses Undergraduate Theses 
2019 
Inhibitory activity of commensals isolated from the bovine teat 
skin microbiota against the major mastitis pathogen 
Staphylococcus aureus 
Theresa J. Astmann 
John W. Barlow 
Follow this and additional works at: https://scholarworks.uvm.edu/hcoltheses 
Recommended Citation 
Astmann, Theresa J. and Barlow, John W., "Inhibitory activity of commensals isolated from the bovine teat 
skin microbiota against the major mastitis pathogen Staphylococcus aureus" (2019). UVM Honors 
College Senior Theses. 278. 
https://scholarworks.uvm.edu/hcoltheses/278 
This Honors College Thesis is brought to you for free and open access by the Undergraduate Theses at 
ScholarWorks @ UVM. It has been accepted for inclusion in UVM Honors College Senior Theses by an authorized 
administrator of ScholarWorks @ UVM. For more information, please contact donna.omalley@uvm.edu. 
   
* Corresponding author. 
 For further correspondence: Theresa.Astmann@uvm.edu  
 
 
   
* Corresponding author. 
 For further correspondence: Theresa.Astmann@uvm.edu  
 
 
  
 
 
 
 
  
 
Inhibitory activity of commensals isolated from the bovine 
teat skin microbiota against the major mastitis pathogen 
Staphylococcus aureus 
Theresa J. Astmann*
a
 and John W. Barlow
a 
 Theresa.Astmann@uvm.edu 
John.Barlow@uvm.edu  
 
 a 221 Terrill, Department of Animal and Veterinary Sciences, University of Vermont, 
Burlington, VT  05405 
 
1 
Abstract 1 
 Many studies suggest that certain potentially beneficial commensal bacteria residing in 2 
the teat skin environment may protect the bovine mammary gland from mastitis by actively 3 
inhibiting colonization by major mastitis pathogens. To investigate the contribution of these 4 
commensals to differences in susceptibility to mastitis observed between healthy cows and 5 
chronically infected cows, teat skin swab samples were collected from 8 mature, lactating 6 
Holstein cows – 4 animals having demonstrated consistently low somatic cell counts and 4 7 
animals having demonstrated consistently high somatic cell counts – and screened for the 8 
presence of organisms demonstrating antagonism against the major mastitis pathogen 9 
Staphylococcus aureus. Presumptive antagonists identified were also individually tested against 10 
a second S. aureus strain to confirm inhibition. 130 isolates total were characterized as S. aureus 11 
antagonists over the course of this study, and 36 representative isolates were selected for 16S 12 
rRNA sequencing to establish species identity. While the original hypothesis was not supported 13 
by the data, potential flaws in study design that may have influenced the results were identified 14 
and used to pinpoint targets to address through further investigation. Ultimately, this study did 15 
support the idea that the bovine teat skin microbiota represents a rich source of Bacillus and 16 
Paenibacillus commensals demonstrating effective S. aureus antagonism which, via the 17 
purification of antimicrobial substances and/or the development of novel probiotics, could 18 
potentially be applied to alternative strategies of mastitis control. 19 
 20 
 21 
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1.  Introduction 25 
 Mastitis is the most common and most costly production disease of dairy cattle, imposing 26 
a considerable economic impact on dairy farmers in Vermont as well as globally and serving as 27 
the principal reason for antibiotic use on farms (Carson et al., 2017; Pol and Ruegg, 2007). 28 
Given the decrease in milk quality that results from infection in one or more quarters as well as 29 
the high risk of infection spreading to other animals, there are major incentives for non-organic 30 
dairy farms to pursue antibiotic treatment of clinical cases of mastitis. Antibiotic use associated 31 
with mastitis control is attributed to both therapeutic as well as prophylactic indications. On 32 
dairy farms in the United States, dry cow therapy represents an extremely significant percentage 33 
of antibiotic use, as over 90% of dairy farms in the U.S. administer intramammary antibiotics at 34 
dry off and at least 80% of these farms implement blanket dry cow treatment for all of their 35 
animals (Oliver et al., 2011). Such extensive antibiotic use places heavy selection pressure on 36 
mastitis pathogens and contributes to the emergence of antimicrobial-resistant strains, 37 
particularly against classes of drugs that are most frequently used for mastitis prevention and/or 38 
treatment, such as cephalosporins and other β-lactams (Oliver et al., 2011).   39 
 Considering the implications for public health posed by growing antibiotic resistance, 40 
there is a significant demand for research focused on mastitis epidemiology to aid in the 41 
development of alternative strategies of mastitis control. The existing mastitis research literature 42 
contains a long history of attempts to characterize the species composition of the bovine 43 
mammary gland microbiota and its relationship to the incidence of disease, and recent studies 44 
have identified a number of commensal species colonizing the teat skin that have either never or 45 
very rarely been associated with cases of mastitis (Falentin et al., 2016). Furthermore, many 46 
studies suggest that certain potentially beneficial commensal bacteria may actually protect the 47 
mammary gland from infection by actively inhibiting colonization by major mastitis pathogens, 48 
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such as Staphylococcus aureus, Streptococcus agalactiae, Streptococcus uberis, Streptococcus 49 
dysgalactiae, and the coliforms (e.g. Escherichia coli and Klebsiella spp.) (Al-Qumber and 50 
Tagg, 2006; Carson et al., 2017; De Vliegher et al., 2004). Further understanding of the 51 
organisms colonizing the teat skin and the potential role of competitive exclusion or growth 52 
antagonism of bacterial species or communities of the teat skin habitat may provide new insights 53 
or tools for mastitis epidemiology and control (Klaas and Zadoks, 2017).   54 
 The production of antimicrobial substances, including antibiotics, bacteriocins, and 55 
antimetabolites, has been widely observed among various species and proposed as a fundamental 56 
mechanism by which certain teat skin commensals confer protection against infection by major 57 
mastitis pathogens (Woodward et al., 1987); these substances may therefore represent a useful 58 
avenue to explore in the search for novel methods of mastitis control. The potential value of this 59 
nature of research is exemplified by a study conducted by Woodward et al. (1987), in which 25% 60 
of isolates obtained from teat skin swab samples collected from dairy heifers – representing 61 
multiple different genera, including Bacillus, Aerococcus, and Corynebacterium – inhibited both 62 
Gram-positive and Gram-negative mastitis pathogens in vitro. More recently, De Vliegher et al. 63 
(2004) described multiple Staphylococcus chromogenes isolates of teat skin origin which were 64 
found to secrete a bacteriocin capable of diffusing through agar gel to inhibit the growth of S. 65 
aureus in vitro, and Barboza-Corona et al. (2009) found that multiple strains of S. aureus were 66 
susceptible to five different bacteriocins produced by Bacillus thuringiensis. The results from 67 
these studies suggest that species of a variety of different genera isolated from the udder 68 
microbiota may serve as a viable source of antimicrobial compounds with the potential to be 69 
applied to mastitis prevention.   70 
4 
 One factor that may help identify individual animals more likely to possess beneficial, 71 
antimicrobial-producing commensals colonizing the mammary gland is somatic cell count 72 
(SCC), defined as the concentration of somatic cells (predominantly leukocytes) per milliliter of 73 
milk. Somatic cell count is widely used in the dairy industry as an indicator of milk quality, but 74 
also has an important role in assessing individual animal health; typically, an SCC lower than 75 
100,000 cells/mL for an individual cow would indicate a healthy animal whereas an SCC greater 76 
than 200,000 cells/mL would suggest a case of intramammary infection (Ruegg and Pantoja, 77 
2013). In a study performed by Al-Qumber and Tagg (2006), milk and teat skin swab samples 78 
were taken from healthy lactating cows selected based upon the observation of consistently low 79 
somatic cell counts; from those samples, bacilli with inhibitory activity against mastitis-80 
associated bacteria were successfully identified, therefore suggesting a potential correlation 81 
between somatic cell count and the presence of mastitis pathogen antagonists.  82 
 The aim of this present study was to sample the teat skin microbiota of adult lactating 83 
Holstein cows from the University of Vermont CREAM herd and screen these samples for 84 
isolates demonstrating antagonism against multiple strains of Staphylococcus aureus originating 85 
from other dairy farms in Vermont. The general hypothesis inspiring this work was that healthy, 86 
mastitis-free cows possess teat skin microbiota with a species distribution that protects against 87 
intramammary infection by major mastitis pathogens such as S. aureus, and that this protective 88 
effect is potentially due to the presence of bacterial strains which secrete antimicrobial 89 
compounds that actively inhibit S. aureus growth and colonization of the mammary gland. It was 90 
therefore hypothesized that healthy cows from the UVM farm with a history of consistently low 91 
milk somatic cell counts would possess a teat skin microbiota with a greater density of S. aureus 92 
antagonists than chronically infected cows from the same farm, established as such based on a 93 
5 
history of consistently high milk somatic cell counts. Upon identifying a set of antagonists 94 
isolated from these samples, the secondary goal of this study was to use 16S genotyping methods 95 
to analyze species composition and diversity among these isolates, comparing similarities and 96 
differences between healthy and chronically infected cows as well as comparing types of species 97 
identified to those characterized as S. aureus antagonists in previous, similar studies. 98 
 99 
2.  Materials and Methods 100 
 101 
2.1.  Study Design 102 
 During three different sampling events over a 5 month period lasting from September 103 
2018 to March 2019, teat skin swab samples were collected from 8 mature lactating Holstein 104 
cows belonging to the CREAM herd of the University of Vermont dairy farm. Cows were 105 
selected based on assessment of the most recent five months of their milk somatic cell count 106 
history, as reported by monthly milk quality testing conducted by the Dairy Herd Improvement 107 
Association (DHIA). 4 mid-lactation cows (ID numbers 3799, 3863, 3814, and 3837) were 108 
chosen for enrollment in Group 1 of the study based on the demonstration of consistently low 109 
somatic cell counts (< 60,000 cells per mL) for at least 5 consecutive months; conversely, 4 mid-110 
lactation cows (ID numbers 3833, 3792, 3864, and 3894)  were enrolled in Group 2 of the study 111 
based on evidence of chronic mastitis represented by consistently elevated milk somatic cell 112 
counts (>280,000 cells per mL) for at least 5 consecutive months. The single exception within 113 
this group was cow 3894, whose somatic cell count had been elevated for only 4 consecutive 114 
months at the time of sampling; this exception was made due to the absence of a fourth animal 115 
within the same herd that fit all of the specifications indicated for Group 2. The number of 116 
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lactations completed by each cow was also taken into account when selecting animals for the 117 
study. With the exception of cow 3894 (a first-calf heifer), animals ranged from second-lactation 118 
dams to fourth-lactation dams, and individuals in each group were matched on the basis of this 119 
parameter. 120 
 121 
2.2  Sample Collection 122 
The procedure used to collect all samples was approved by the University of Vermont 123 
Institutional Animal Care and Use Committee prior to the beginning of the study (IACUC 124 
protocol #19-014). Teat skin swab samples were collected while the animals were standing in the 125 
milking parlor for their normal afternoon milking. Samples were taken from all four teats, at 126 
three different locations on or inside the teat: the external teat barrel (TB), the external teat end 127 
(TE), and within the distal streak canal (SC). Before collecting a sample, any obvious fecal 128 
debris or bedding material was removed from the teat surface using a clean, non-sterile towel. 129 
Samples were then collected using sterile swabs (100 mm normal flocked swabs were used for 130 
TB and TE samples while 80 mm mini-tip flocked swabs were used to access the internal streak 131 
canal) dipped in sterile water. Swabs were kept on ice in tubes of sterile water and transported 132 
back to the lab immediately following the completion of sampling. Samples were vortexed for 5 133 
minutes prior to sterile removal of the swab and then stored in 1 mL aliquots at -20 °C.  134 
 135 
2.3  Antagonism Assays 136 
To initially screen samples for the presence of S. aureus antagonists, samples were 137 
inoculated in serial ten-fold dilutions out to 10
-3
 on Tryptic Soy Agar with 5% sheep blood 138 
(Northeast Laboratory) and tested for simultaneous antagonism against SA AC8-MS3, a S. 139 
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aureus strain isolated from the bulk tank of an organic Vermont dairy farm. Briefly, on day 1 of 140 
this trial, plates were inoculated with 100 μL of sample and incubated for 24 hours at 37°C. After 141 
24 hours, the number of colony-forming units (CFUs) on each plate was counted, and the agar 142 
gel was flipped onto the lid of the plate by circularly loosening and freeing the gel with a 143 
sterilized spatula. On the newly exposed side of the agar, 100 μL of a 1:1000 dilution of a 0.5 144 
McFarland solution of SA AC8-MS3 was inoculated and spread across the plate using a sterile 145 
L-shaped cell spreader. Following another 24 hours of incubation, plates were interpreted by 146 
determining the number of zones of inhibition, as indicated by clear zones of no S. aureus 147 
growth. When possible (i.e. provided that the density of colonies on the original side of the agar 148 
was light enough that separate colonies could be differentiated), a sterile scalpel was used to cut 149 
into the agar around the presumptive antagonist so that this colony could be picked up with a 150 
sterile inoculating loop and streaked on a new blood agar plate. 151 
Following establishment of pure cultures, each isolate was then tested against an 152 
additional S. aureus isolate to confirm inhibition. SA CP20, an isolate derived from an infected 153 
quarter of a cow on a Vermont dairy farm which was found to be strongly inhibitory against 154 
numerous strains of S. chromogenes as well as other strains of S. aureus from the same farm 155 
(Bachmann et al., unpublished), was chosen as the indicator strain for this assay as it was 156 
expected to be a more robust S. aureus strain as compared to others. Isolates were individually 157 
tested using the functional simultaneous antagonism assay previously described by De Vliegher 158 
et al. (2004). Briefly, this method involves inoculating a 0.5 McFarland solution of the isolate 159 
being tested as a growth antagonist as a single streak across the center of a blood agar plate, 160 
incubating at 37°C for 24 hours, and again flipping the agar gel using a sterilized spatula. On the 161 
opposite side of the gel, a 1:1000 dilution of a 0.5 McFarland solution of SA CP20 was 162 
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inoculated as a lawn across the surface. Following an additional 24 hours of incubation, each 163 
plate was examined for evidence of inhibition by looking for a zone of no S. aureus growth 164 
overlaying the original center streak of the presumptive inhibitor strain. When present, the width 165 
of this zone of inhibition was measured in centimeters. Control plates were also implemented in 166 
this assay by testing each isolate against itself, using a 1:1000 dilution of the same 0.5 167 
McFarland solution to inoculate the flipped side. Additionally, the same diluted solution of SA 168 
CP20 used for each of the test plates was inoculated on a fresh blood agar plate to serve as a 169 
negative control and to demonstrate the growth pattern expected in the absence of an inhibitor.  170 
 171 
2.4  16S rRNA Sequencing and Species Identification 172 
 36 representative isolates from the overall set of inhibitors identified were chosen for 16S 173 
rRNA gene sequencing and species identification. Isolates were selected based on the apparent 174 
strength of inhibition demonstrated as well as through comparison of macroscopic morphology 175 
to other inhibitors identified, such that those chosen to be sequenced out of the greater set of all 176 
inhibitors would theoretically represent the overall diversity of species present. DNA extraction 177 
was performed on these selected isolates grown for 12-24 hrs at 37 °C in Trypticase Soy Broth 178 
(BD ™) using the Qiagen DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany), and 179 
extracted DNA was stored at -20 °C. Forward and reverse 16S rDNA primers (Table 1) first 180 
described by Wilson et al. (1990) and subsequently utilized by Al-Qumber and Tagg (2006) in 181 
the identification of Bacillus spp. isolated from the bovine teat skin microbiota were used to 182 
perform polymerase chain reaction in a Bio-Rad® C1000 thermal cycler. PCR reactions were 183 
carried out using 5 μL of 10X PCR buffer, 3 μL of 50 mM MgCl2, 1 μL of each primer, 1 μL of 184 
10 mM deoxynucleotide mix, 0.5 μL of Platinum Taq polymerase, 2 μL of bacterial DNA, and 185 
9 
36.5 μL of sterile molecular grade water to achieve a volume of 50 μL per reaction. After initial 186 
denaturation at 95 °C for 3 minutes, subsequent denaturation reactions were performed at 95 °C, 187 
annealing reactions at 41 °C, and elongation reactions at 72 °C for 30 seconds each; these 188 
conditions were repeated for a total of 30 cycles, after which the final elongation step was carried 189 
out at 72 °C for 10 minutes. Gel electrophoresis was used to verify the success of the 16S 190 
primers and of each round of PCR amplification by confirming the visualization of bands at 191 
approximately 790 base pairs for each isolate (Figure 8), as described by Wilson et al. (1990). 192 
 Each sample of PCR product was treated with ExoSAP-IT™ (ThermoFisher Scientific) 193 
to clean up excess primer and nucleotides and subsequently submitted to the Vermont Integrative 194 
Genomics Center of the UVM Medical Center for 16S rRNA sequencing. Forward and reverse 195 
sequences were trimmed and aligned using Geneious® software in order to determine an overall 196 
consensus sequence to then be entered into the search engine of the NCBI BLAST database and 197 
compared to other known DNA sequences. 198 
 199 
3.  Results 200 
 201 
3.1  Screening Assays 202 
 In total, 96 skin swab samples from three different locations (teat barrel, teat end, and 203 
streak canal) on all four quarters of 8 cows were tested for the presence of S. aureus antagonists. 204 
All cows from Group 1 (low somatic cell count group) were sampled during one session at the 205 
beginning of the study and these samples remained frozen at -20 °C until ready for screening; in 206 
contrast, sample collection for Group 2 (high somatic cell count group) was divided into two 207 
sampling sessions focused on two cows each. This difference was due to the fact that at the time 208 
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of the first sampling session for Group 1, four cows were available that fit the specifications for 209 
this group, whereas at the time of the first sampling session for Group 2, only two cows had 210 
demonstrated high somatic cell counts for five consecutive months. Therefore, subsequent 211 
sample collection was delayed until two more animals qualified for the study.  212 
 Samples were diluted in series as needed in order to obtain accurate CFU counts and 213 
permit differentiation between potential inhibitory colonies. Generally, samples of streak canal 214 
(SC) origin had much fewer organisms present than samples of teat end (TE) or teat barrel (TB) 215 
origin; therefore, SC samples were usually tested at a maximum of one ten-fold dilution while 216 
TE and TB samples were diluted out to 10
-2
 or 10
-3
. If multiple inhibitors were clustered together 217 
on the original side of the agar gel, causing zones of inhibition to overlap, the number of zones 218 
on the plate was estimated as carefully as possible. If the density of inhibitors on the original side 219 
of the gel was high enough that the zones of inhibition could not be differentiated from one 220 
another at all, the plate was recorded as having too many zones to count. Since many of the 221 
undiluted sample plates had very high CFU counts and completely overlapping zones of 222 
inhibition, only potentially inhibitory colonies that were reasonably well isolated were picked up 223 
with a sterile loop and cultured for further testing. Therefore, not all colonies that demonstrated 224 
inhibition were chosen for the individual antagonism assays. An example of a test plate 225 
demonstrating the presence of a well-isolated S. aureus antagonist can be seen in Figure 1. 226 
 To compare the frequency of inhibitors between the low somatic cell count group and the 227 
high somatic cell count group, the ratio of the number of zones of inhibition observed to the total 228 
CFU count in the sample (both calculated as values per mL based on the final dilution factor of 229 
the best countable plate) was analyzed (Figure 3). For modeling purposes, this data was 230 
transformed to a log scale in order to normalize the distributions. Data points that were 231 
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significant outliers or considered untrustworthy were removed from the data set prior to analysis. 232 
For example, a plate in which only 1 colony grew and that colony demonstrated a zone of 233 
inhibition resulted in a ratio of 1.0; however, this value was not trusted because it is extremely 234 
unlikely that 100% of CFUs from that sample were antagonists. The majority of these unreliable 235 
data points came from samples of SC origin, as many of these plates had very low overall CFU 236 
counts (i.e. less than 10). Data points from plates where no colonies grew at all were also 237 
removed because these plates did not give any information about the frequency of inhibitors in 238 
the sample. Samples that were kept in the freezer for longer before testing (for example, samples 239 
from cow 3799, which were worked with last out of the set of samples from Group 1 and had 240 
been kept frozen for about three months) tended to result in poorer overall growth on all plates. 241 
 Greater variation in the ratio of zones of inhibition to total CFU count was observed 242 
among Group 1 as compared to Group 2 (Figure 3). The average zones-total CFU count ratio 243 
was 0.4867 ± 0.0641 for Group 1 and 0.5832 ± 0.0388 for Group 2. The results of an 244 
independent t-test performed to compare these means indicated that the difference between them 245 
was not statistically significant (p = 0.1857, df = 73). The average zones-total CFU count ratio 246 
was also compared among different sampling locations (Figure 4). Of the three sample locations, 247 
samples isolated from the streak canal had the lowest average zones-total CFU count ratio (M = 248 
0.2756 ± 0.0675) while samples isolated from the teat barrel had the highest average ratio (M = 249 
0.6649 ± 0.0508). A one-way ANOVA was performed to compare these means and a statistically 250 
significant difference was observed between means (p < 0.0001, df = 2). 251 
 The log of zones of inhibition per mL was also plotted as a function of the log of CFU 252 
count to determine if a linear relationship existed between these two variables (Figure 5). 253 
Regression analysis was performed and a positive linear relationship was supported (m = 0.875, 254 
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R
2
 = 0.424), suggesting that the number of zones of inhibition increases as the total CFU count 255 
of a sample increases. 256 
 257 
3.2  Individual Antagonism Assays 258 
 130 isolates were generally characterized as S. aureus antagonists over the course of this 259 
study. 57 of these isolates originated from samples obtained from Group 1 and 73 isolates 260 
originated from samples obtained from Group 2. Figure 2 shows an example of an isolate 261 
demonstrating successful SA CP20 inhibition on an individual test plate, as compared to two 262 
types of control plates. Each antagonist was classified into one of four categories based on the 263 
width of the zone of inhibition measured on the SA CP20 test plate and/or the overall pattern of 264 
inhibition observed (Table 2).  265 
 Control plates were performed for each antagonist tested. On almost all control plates, a 266 
narrow zone of no growth directly overlaying the initial streak (and often the zone of hemolysis) 267 
was observed (Figure 2). In these cases, growth typically stopped very abruptly at the border of 268 
the initial streak or zone of hemolysis, with potentially two or three colonies invading into the 269 
outer edges of the zone. In contrast to true SA CP20 inhibition, this pattern of growth was 270 
suspected to be the result of minimal nutrient availability at that zone of the gel due to thick 271 
growth at the level of the initial streak. Therefore, SA CP20 test plates were compared to control 272 
plates in order to verify inhibition, and plates with a narrow zone of inhibition in which SA CP20 273 
growth only stopped adjacent to the zone of hemolysis were suspected of demonstrating weak or 274 
non-inhibitors, with regards to their activity against SA CP20 (Table 2). 275 
 276 
 277 
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3.3  Species Identification 278 
 Based on microscopic and macroscopic morphology as well as preliminary Gram 279 
staining, antagonists were presumptively established as members of the Bacillus genus. This was 280 
also supported by gel electrophoresis which confirmed the success of the primers PC3mod and 281 
P0mod in PCR amplification of the 16S gene (Figure 8), which had been used previously to 282 
classify unknown isolates as Bacillus spp. (Al-Qumber and Tagg, 2006). 36 representative 283 
isolates demonstrating a clear zone of inhibition were selected for 16S sequencing, and all 36 284 
isolates were established as members of either the Bacillus or Paenibacillus genus. Due to major 285 
similarities within the 16S gene observed between species of these genera, the comparison 286 
results for sequences entered into the BLAST search engine typically came up with multiple 287 
species demonstrating 99-100% matching identity for each isolate. Therefore, isolates could not 288 
be completely narrowed down to the individual species level and were instead classified as 289 
belonging to a particular species cluster consisting of two or more species between which 16S 290 
sequencing was unable to discriminate.  291 
 The four main species clusters identified, in order of decreasing frequency of observation, 292 
were established as follows: (1) the Bacillus pumilus* cluster (*indistinguishable from B. 293 
zhangzhouensis, B. safensis, B. australimaris, B. aerophilus, B. altitudinis, or B. 294 
stratosphericus), (2) the Bacillus licheniformis** cluster (**indistinguishable from B. haynesii, 295 
B. paralicheniformis, or B. glycinifermentans), (3) the Paenibacillus barcinonensis*** cluster 296 
(***indistinguishable from P. amylolyticus, P. oceanisediminis, or P. silvae), and (4) the 297 
Paenibacillus cookii**** cluster (****indistinguishable from Acetobacter pasteurianus or P. 298 
relictisesami). A higher frequency of inhibitors with zones of inhibition greater than 3 cm wide 299 
was observed among B. pumilus* and B. licheniformis** isolates as compared to the two 300 
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Paenibacillus species clusters, with no Paenibacillus isolates demonstrating zones of inhibition 301 
falling into the uppermost range for zone width (i.e. greater than 5 cm) (Figure 6). The 302 
proportions of inhibitors identified as B. pumilus* with zone widths in the middle range (3.1-5 303 
cm) and the uppermost range (greater than 5 cm) were markedly higher than the proportions of 304 
all other species clusters in each respective category (Figure 6). The frequency of isolates 305 
identified as B. pumilus* among sequenced isolates from the low somatic cell count group was 306 
also higher than the frequency of B. pumilus* isolates among sequenced isolates from the high 307 
somatic cell count group; the opposite trend was true for B. licheniformis** and P. 308 
barcinonensis*** (Figure 7). No isolates identified as P. cookii**** were isolated from the high 309 
somatic cell count group.  310 
 311 
4.  Discussion 312 
 In this study, no significant difference was reported in the ratio of zones of inhibition to 313 
total CFU count between Groups 1 and 2. Therefore, the hypothesis that a higher frequency of S. 314 
aureus antagonists would be observed among the low somatic cell count group as compared to 315 
the high somatic cell count group was not supported. However, the apparent presence of a 316 
positive, linear relationship between the total CFU count and the number of zones of inhibition 317 
(Figure 5) does suggest that total CFU count may be a predictor of the density of S. aureus 318 
antagonists present within the microbial community of the teat environment – in essence, that 319 
“dirtier” teats result in a higher frequency of antagonists because this frequency is simply a 320 
function of the number of microorganisms present and is not necessarily related to the infection 321 
status of the mammary gland. This hypothesis is also supported by the fact that a higher mean 322 
zones-total CFU count ratio was observed among samples from the teat barrel as compared to 323 
15 
samples from the teat end or streak canal (Figure 4), as TB samples typically had the highest 324 
initial CFU counts.  325 
 The theory that antagonist frequency might be a function of CFU density is logical 326 
because all of the antagonists identified were established as members of either the Bacillus or 327 
Paenibacillus genus, both of which are largely comprised of soil bacteria that would be 328 
ubiquitous in a farm environment and therefore naturally present on the surface of the teat skin. 329 
Previous studies have already indicated that Bacillus spp. make up a significant percentage of the 330 
normal bovine teat skin microbiota, and that many of these species demonstrate inhibitory 331 
activity against mastitis pathogens (Al-Qumber and Tagg, 2006; Woodward et al., 1987, 1988). 332 
Provided that the proportion of the microbial community consisting of Bacillus spp. is relatively 333 
constant, a teat surface colonized by a higher number of microorganisms would inevitably have a 334 
higher number of Bacillus organisms present and thus, in theory, a higher number of antagonists 335 
present. This finding does not, however, explain the difference in susceptibility to intramammary 336 
infection observed between the high and low somatic cell count groups, which may be more tied 337 
to individual cow factors than teat skin microbiota factors, or which could potentially be 338 
elucidated by further investigation into this specific area of research. 339 
 It is important to note that the original hypothesis does not factor the respective inhibitory 340 
strength of these antagonists into the equation, which could potentially represent an important 341 
piece of the puzzle. Bacillus pumilus* was identified as the species cluster with the highest 342 
frequency of inhibitors producing zone widths in both the middle (3.1-5 cm) and upper ranges (> 343 
5 cm) of the spectrum (Figure 6), and the proportion of sequenced Group 1 isolates represented 344 
by members of this species cluster was higher in comparison to the proportion of sequenced 345 
Group 2 isolates (Figure 7). The observation of greater zone widths does not necessarily 346 
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establish isolates as “stronger” inhibitors, as there may be other confounding variables at play at 347 
the molecular level (i.e. rates of diffusion through the agar) which have not yet been fully 348 
assessed; however, it is certainly possible that those isolates produced antimicrobial compounds 349 
which were structurally different from those which typically fell into the lower ranges for zone 350 
width and potentially more effective in terms of the extent of their activity. If this were true, it 351 
would be conceivable to imagine based off of the results from this study that there might be a 352 
difference in the frequency of isolates and species producing more effective antimicrobial 353 
substances between the two study groups, and that variation in this parameter as opposed to the 354 
overall frequency of inhibitors present might play more of a role in determining individual cow 355 
susceptibility. Sequencing of the remainder of the antagonists identified in this study would 356 
provide more data from which to draw conclusions regarding the relative frequencies of 357 
individual species; given that 16S sequencing was unable to differentiate between numerous 358 
species within the two main genera identified, targeting a different gene – such as the rpoB 359 
housekeeping gene, which has demonstrated success in enabling differentiation between more 360 
closely related Bacillus and Paenibacillus species (Durak et al., 2006) – may be useful in 361 
gathering more precise species data. Additionally, further characterization of the antimicrobial 362 
substances described in this study would be a helpful first step toward better understanding their 363 
respective levels of activity and modes of action, as well as how these factors may be related to 364 
the relative “strength” of each individual inhibitor. 365 
 There are several factors related to study design that may have influenced the results of 366 
this study and that could also serve as targets for continuation of this work. First, it is possible 367 
that the different lengths of freezer storage time between low SCC samples and high SCC 368 
samples may have skewed the data, as samples from cow 3799 (which, out of all samples, were 369 
17 
stored in the freezer for the longest before testing) had very minimal growth all around and likely 370 
did not reflect the true microbial community associated with the teat skin of that animal. Since 371 
samples were initially frozen in sterile water as opposed to a glycerol growth medium designed 372 
to support long-term storage, it may be possible that CFU count decreased with the length of 373 
storage time, and this could have easily affected the data for the low SCC group. Since all high 374 
SCC samples were worked with closer to the original sampling date, this could have influenced 375 
the antagonist frequency results to be more accurate for Group 2 and potentially less accurate for 376 
Group 1 (at least for samples analyzed last, which still made up a significant percentage of the 377 
overall data set for Group 1). This would account for the more extensive variation observed in 378 
the data for Group 1 as compared to Group 2 (Figure 3). Therefore, for future continuation of 379 
this work, it would most likely be prudent to collect fewer samples at a time and test them sooner 380 
to avoid potential deterioration of the samples over time. 381 
 An additional factor to consider when analyzing the results of the data in terms of the 382 
original hypothesis is the fact that neither of the two S. aureus isolates used as indicator strains 383 
originated from the UVM CREAM herd. Therefore, the results from this study do not necessarily 384 
reflect the specific relationship between antagonists isolated from the teat skin microbiota and 385 
the pathogen strains that they presently co-exist with, some of which may have developed 386 
adaptations to make them more resistant to antimicrobial substances produced by antagonists 387 
residing in the same niche. It may be possible that some of the isolates that actively inhibited 388 
both S. aureus strains in this study would fail to inhibit S. aureus strains originating from the 389 
same farm, which have potentially accumulated mutations providing them with growth 390 
advantages specific to their own environment and which may include resistance to certain 391 
antimicrobials. As a follow-up study, it would be worthwhile to test all antagonists identified in 392 
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this study against two or more S. aureus strains isolated from clinical cases of mastitis at the 393 
UVM farm, and then compare those results between low and high SCC cows and between 394 
different species. If resistance to these antagonists was more frequent among the high SCC group 395 
compared to the low SCC group, this could potentially support the original hypothesis – in other 396 
words, even though the present study suggests that both groups have a similar density of 397 
antagonists, it may be true that cows more resistant to mastitis have a teat skin microbiota 398 
favoring a higher density of antagonists that are more competitive in their specific environment, 399 
as a result of the production of antimicrobial substances with a stronger effect against indigenous 400 
mastitis pathogens. 401 
 The simultaneous antagonism assay described by De Vliegher et al. (2004) was chosen to 402 
test individual isolates for S. aureus antagonism because this method specifically allows for the 403 
identification of isolates which exert their inhibitory effect through the production of diffusible 404 
antimicrobial compounds; patterns of inhibition more likely to be caused by other factors, such 405 
as nutrient competition, can easily be distinguished through the aid of control plates (Figure 2). 406 
The production of antimicrobial compounds by bovine teat skin commensals with activity 407 
against mastitis pathogens has been observed among coagulase-negative staphylococci, 408 
numerous Bacillus and Paenibacillus spp., and other species (Carson et al., 2017; Nascimentoa 409 
et al., 2005; Ding et al., 2011). Bacitracin, an antibiotic with widespread clinical use that is 410 
known to be effective against S. aureus, is one example of a well-characterized antimicrobial 411 
peptide produced by B. licheniformis (Sumi et al., 2014) and one which may have been produced 412 
by certain isolates classified as members of the B. licheniformis** cluster. Follow-up analysis of 413 
the antagonists identified in the present study should include purification and characterization of 414 
the antimicrobial compounds being produced, along with comparison to conventional antibiotics 415 
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such as bacitracin. Subsequent in vitro testing could be employed to measure the susceptibility of 416 
a panel of different S. aureus strains to these compounds, quantify their minimum inhibitory 417 
concentrations (MICs), and assess the potential development of resistance. Such work could 418 
ultimately inform future in vivo studies designed to assess the efficacy of antibiotics derived 419 
from the normal microbiota of the teat skin in prophylactic and/or therapeutic management of 420 
mastitis. 421 
 The present research supports the idea proposed by Al-Qumber and Tagg (2006) 422 
suggesting that S. aureus antagonists of the Bacillus genus may merit further consideration in 423 
terms of their potential application as a probiotic designed to support mammary gland health 424 
(and also identifies antagonists of the Paenibacillus genus which could be applied for this use as 425 
well). The idea of intentionally colonizing the mammary gland with species known to be 426 
inhibitors of mastitis pathogens to confer protection against these pathogens is not novel 427 
(Matthews et al., 1990); however, the main downside of this strategy is the risk of the new 428 
species introduced causing more harm than benefit by triggering an elevation in somatic cell 429 
count. The advantage of using antagonists such as those identified in this study (particularly 430 
those isolated from Group 1 cows) would be that these species make up part of the normal 431 
microbiota of the teat surface and streak canal and therefore would not be expected to negatively 432 
impact the mammary gland as a result of their colonization. In a recent appraisal of the potential 433 
of probiotics as a strategy for mastitis control, it was concluded that although requiring extensive 434 
research prior to implementation, a probiotic delivered at the level of the teat apex (as opposed to 435 
intramammary or oral delivery) could hypothetically offer a real possibility of preventing 436 
mastitis (Rainard and Foucras, 2018).  Numerous Bacillus spp. are already widely used as 437 
probiotics to supplement the diet in humans and animals, including B. coagulans, B. clausii, B. 438 
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cereus, B. subtilis, and B. licheniformis (Mingmongkolchai and Panbangred, 2018). The general 439 
safety of these species in addition to their demonstrated capacity to shift the balance within the 440 
microbiome to favor overall eubiosis has established them as effective probiotics for 441 
gastrointestinal health, indicating that certain Bacillus species could reasonably have the same 442 
effect on mammary gland health.  443 
 Good hygiene practices (i.e. bedding management, milking system sanitation, overall 444 
farm cleanliness etc.) serve as the first and most important step in controlling mastitis, but due to 445 
the ubiquity of pathogens in the environment, it can be challenging to keep animals infection-446 
free even under the best of management systems. Antimicrobial drugs are currently the best tool 447 
available to farmers and veterinarians in treating cases of mastitis once they arise, and are also 448 
used heavily in a prophylactic sense on most farms in the U.S. to help protect the mammary 449 
gland for future lactations once cows enter the dry off period. Such a high dependence on these 450 
drugs for maintaining herd health, however, poses serious risks for livestock and humans alike as 451 
antibiotic resistance becomes a rapidly growing public health concern. Research focused on 452 
addressing knowledge gaps in mastitis epidemiology as well as investigating novel mastitis 453 
treatment strategies is of critical importance in supporting the goal of reducing the use of 454 
antibiotics in agricultural practices. Reflecting the increasing level of significance that is 455 
currently being accorded to the microbiome by emerging research in the field, the findings in this 456 
present study ultimately contribute to a growing understanding of the importance of the 457 
relationship between eubiosis within the udder and teat skin microbiota and overall animal 458 
health. 459 
 460 
 461 
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5.  Conclusion 462 
 Although the original hypothesis that a significant difference would be observed between 463 
the frequency of S. aureus antagonists isolated from healthy, low somatic cell count cows and 464 
chronically infected, high somatic cell count cows was not supported, the present study was 465 
successful in identifying numerous isolates from both groups with the capacity to inhibit the 466 
growth of two different strains of S. aureus. Furthermore, multiple factors have been identified 467 
that may have influenced the data and are worth further investigation before ruling out the 468 
hypothesis. Ultimately, the findings in this study support those reported in other similar studies 469 
which suggest that the teat skin microbiota is a rich source of commensals, particularly those of 470 
the Bacillus and Paenibacillus genera, with the capacity to secrete antimicrobial compounds 471 
effective in inhibiting the growth of S. aureus. Be it through purification and characterization of 472 
these compounds or through assessment of the suitability of these commensals for use as a 473 
probiotic, the S. aureus antagonists identified in this study offer a wealth of further research 474 
avenues to explore and suggest that Bacillus and Paenibacillus species with a demonstrated 475 
range of activity against mastitis pathogens may represent a valuable resource in the 476 
development of alternative methods of mastitis control. 477 
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Table 1: PCR primers used for 16S sequencing 591 
Primer Sequence 
PC3mod (forward) 5’  GGA CTA HAG GGT ATC TAA T  3’ 
P0mod (reverse) 5’ AGA GTT TGA TCM TGG  3’ 
 592 
 593 
 594 
Table 2: Distribution and classification of S. aureus antagonists identified from all cows enrolled 595 
in the study.  596 
Cow                                       Zone of Inhibition Width 
 Weak
a
 ≤ 3 cm 3.1-5 cm > 5 cm
b 
Total 
3863 1 4 4 6 15 
3814 1 5 5 2 13 
3837 4 8 8 2 22 
3799 0 1 3 3 7 
3792 1 12 5 1 19 
3833 0 5 10 2 17 
3864 3 0 10 5 18 
3894 2 6 6 5 19 
Total 12 41 51 26 130 
 597 
a 
Isolates for which the test plates demonstrated SA CP20 growth very close up to the zone of 598 
hemolysis/initial streak were perceived as weak or questionable inhibitors.  599 
 600 
b 
Includes isolates for which SA CP20 growth was completely absent. 601 
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Figure 1  Test plate demonstrating a clear zone of 
SA AC8-MS3 inhibition around the colony at the top 
of the plate 
Figure 2  Right: example of test plate 
demonstrating SA CP20 inhibition by an 
isolate characterized as a very strong inhibitor; 
Bottom left: example of control plate in which 
the same isolate is inoculated on both sides of 
the gel (note lack of growth along central 
streak); Bottom right: example of negative 
control plate demonstrating dense growth of 
diluted SA CP20 in the absence of an inhibitor 
streak 
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Figure 3  Box-and-whisker plot representing the lower and upper extremes, lower and upper quartiles, and medians of the zone-
total CFU count ratios for both groups of the study, with outliers and untrustworthy data points removed (n = 75). More extensive 
variation in the data is evident in the distribution for Group 1, representing the low somatic cell count cows, as compared to Group 
2. The difference in mean ratio values between Groups 1 and 2 (M1 = 0.4867 ± 0.0641, M2 = 0.5832 ± 0.0388) was not determined 
to be statistically significant (p = 0.1857, df = 73). 
28 
 
 
 
Figure 4  Box-and-whisker plot comparing the distribution of the ratio of zones of inhibition to total CFU count among the three 
sampling locations on the teat: the streak canal (SC), the teat barrel (TB), and the teat end (TE). Outliers and untrustworthy data 
points have been removed from the model (n = 75). The results of one-way ANOVA indicated that the difference in mean ratio 
values between sampling locations (MSC = 0.2756 ± 0.0675, MTB = 0.6649 ± 0.0508, MTE = 0.5651 ± 0.0526) was statistically 
significant (p < 0.0001, df = 2), with the teat barrel having the highest mean zone-total CFU count ratio and the streak canal 
representing the lowest. 
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Figure 5  Linear regression model depicting a positive linear trend (m = 0.875) in the relationship between the total CFU count 
per mL and the zones of inhibition per mL, with outliers and untrustworthy data points removed (n = 75). The R
2
 value is 0.424, 
indicating that the model accounts for 42.4% of the variation in the data. 
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Figure 6  Bar graph comparing the observed frequencies of each species cluster with respect to width of zone of inhibition. 
Frequencies were calculated by determining the number of isolates of a given species cluster classified into a specific range 
based on width of zone of inhibition and dividing by the total number of isolates demonstrating a zone of inhibition falling 
within that range (ntotal = 36). 
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Figure 7  Bar graph comparing the distribution frequencies of each species cluster between Groups 1 and 2. Frequencies were 
calculated by determining the number of isolates identified as members of a given species cluster and dividing by the total 
number of isolates sequenced from that group (nGroup 1 = 24, nGroup 2 = 12; ntotal = 36). 
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 615 
Figure 8  Gel demonstrating successful PCR amplification of the 16S gene on 14 isolates using the 
primers PC3mod and P0mod, as indicated by the presence of clear, dark bands of approximately 790 
base pairs. Lane 1 represents the DNA ladder, and lanes 2 and 10 represent negative controls. 
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Reflection 616 
 Although the DUR process was one of the most challenging undertakings of my 617 
academic career, it is one that I am extremely glad I chose to pursue. I am grateful to have had 618 
the opportunity to design a research project tailored to my scientific interests and see it through 619 
to the end, through all the highs and lows that I encountered along the way. I believe that a rather 620 
unique aspect of Dr. Barlow’s laboratory as compared to others is the level of independence that 621 
is accorded to his students; while it may have been a bit unnerving at first, I quickly learned the 622 
necessity of taking initiative and now understand how beneficial this has been for my own 623 
personal and academic growth. I have come to realize that I am the kind of student who really 624 
values and enjoys individual work because it allows me to set my own standards of rigor and 625 
challenge myself to reach or even exceed them.  626 
 Throughout this process I have had to learn how to perform numerous different 627 
procedures rather quickly and then be able to perform them on my own right away, as a result of 628 
which I have gained a strong sense of confidence when it comes to a variety of methods and 629 
techniques commonly utilized in the fields of microbiology and molecular biology. I can 630 
truthfully say that I have devoted hundreds of hours to the lab over the past year, and while I did 631 
receive help on some occasions from fellow students, for the most part I completed all of the wet 632 
lab work on my own. I definitely benefitted from Dr. Barlow’s support when I had questions or 633 
ran into issues, but I also become increasingly more independent over the course of this project 634 
in terms of troubleshooting problems on my own. I would first seek out answers in the research 635 
literature when I had questions, and often found myself getting inspired with new hypotheses to 636 
consider or ideas to explore. 637 
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 The most important thing I will take away from this experience is the realization of how 638 
much I enjoy independent research. Despite the long hours spent in the lab, the setbacks I 639 
encountered, and the stress of the past few months, throughout the entire process I genuinely felt 640 
passionate about the work I was doing. Ultimately, the time crunch that I ran into toward the end 641 
– the greatest challenge I had to overcome during this process – was due to my own obstinacy in 642 
wanting to collect more data that I was personally interested in but which was theoretically 643 
superfluous in terms of the amount I needed for an undergraduate-level thesis. I pushed myself 644 
harder than I ever have before to finish all of my data collection on time, but ultimately I feel that 645 
the work I put into this project paid off and I will submit this document feeling proud of what I 646 
have accomplished. I also plan to continue working on this research over the coming months and 647 
hope to have a manuscript worthy of publication by the end of the summer. 648 
 For most of my college career, I have envisioned veterinary school and veterinary 649 
practice as my determined path; now, I have begun to consider the other options that are 650 
available to me, particularly those associated with research. My new plan is to attend graduate 651 
school for a Master’s thesis in animal science or microbiology, after which I may decide to 652 
pursue a dual DVM/PhD degree. While I am still interested in going into practice, I can also see 653 
myself staying in academia and focusing my career on conducting research within some sector of 654 
veterinary medicine. Regardless of what I do decide on, completing the DUR has been a truly 655 
invaluable part of my college experience and has given me a novel appreciation for the scientific 656 
process and the field of veterinary microbiology as a whole. I am excited to see where this leads 657 
me next! 658 
